Biopsy Devices Market Became a Highly Profitable Industry: Revenue Analysis and Industry Forecast, 2017-2023

Biopsy Devices Market was valued at $1,621 million, and is expected to reach $2,399 million by 2022, supported by a CAGR of 5.8%. Biopsy is the surgical removal of tissue from an organ to determine the presence or extent of a disease, mostly cancerous and inflammatory conditions. Increasing incidences of cancer such as breast, prostate, & lung, and rapid technological advancements have been stimulating the growth of the biopsy devices market.

Breast biopsy application segment is expected to continue to lead the market because of increased incidences and mortality rates of breast cancer. Moreover, initiatives by various government bodies to spread the awareness about breast cancer is expected to supplement the growth of the breast biopsy devices market. Breast biopsy is followed by liver & bile duct biopsy, which is the second highest revenue-generating application segment globally.

Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/1424

Biopsy devices market isowing to increase in several types of cancer such, as breast, prostate, & lung, and rapid technological advancements in the field of diagnostics. The emerging economies have witnessed an upsurge in the prevalence of chronic diseases due to increase in the aged population and change in lifestyles. The Emergence of novel biopsy techniques and advanced integrated imaging technology, such as MRI, CT, ultrasound scan, and others, are expected to supplement the diagnosis of chronic diseases namely, cancer using biopsy procedures. However, high cost associated with advanced biopsy technologies may restrict the market growth.

Key Findings of Biopsy Devices Market:

• CT-guided biopsy segment is anticipated to grow at the highest CAGR of 6.3% during the forecast period.
• The diagnostic centers would continue to lead the revenue generating end use segment by garnering around half of the share in the overall market.
• Lung biopsy is projected to be the fastest growing application segment, registering a CAGR of 7.0%.
• The robotic guidance system segment is expected to register the highest CAGR of 7.0%.
• The Asia-Pacific region is projected to be the fastest growing market, with a CAGR of 7.2%.
• Hospitals are projected be the fastest growing end use segment, owing to increase in integration of diagnostic facilities within the premises.

North America was the highest revenue generating region due to rise in incidences of chronic diseases in 2015. North America and Europe, collectively, accounted for more than three-fourths of the overall market in 2015; this trend is likely to continue over the forecast period. Factors that drive the growth of biopsy devices in the developed regions are awareness about cancer diagnosis, high purchasing power, and availability of skilled personnel to perform biopsy procedures.

The key companies profiled in the report are C.R. Bard, Inc., Leica Biosystems, Hologic, Inc., Becton, Dickinson and Company, Ethicon EndoSurgery Inc., Fujifilm Medical Systems, Veran Medical Technologies, Boston Scientific Corporation, MDxHealth, Mauna Kea Technologies, Cook Medical, Inc., Medtronic, Argon Medical Devices, Inc, Intact Medical Corp., and others.

Get More Details @ https://www.alliedmarketresearch.com/purchase-enquiry/1424

Table Of Content

Chapter: 1 INTRODUCTION
1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology
1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY
2.1 CXO perspective
2.2 Market beyond: what to expect by 2025
2.2.1 Moderate growth scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario

Chapter: 3 BIOPSY DEVICE MARKET OVERVIEW
3.1 Market definition and scope
3.2 Market Dynamics
3.2.1 Top impacting factors
3.2.2 Drivers
3.2.3 Restrains
3.2.4 Top winning strategies
3.3 Porters Five Forces analysis
3.3.1 Fewer suppliers lead to higher bargaining power of suppliers
3.3.2 Higher concentration of buyers leads to low bargaining power
3.3.3 High threat of substitutes due to presence of minimal invasive diagnostic procedures
3.3.4 Low threat of new entrants due to high capital investment
3.3.5 Moderate competitive rivalry
3.4 Value chain analysis
3.4.1 Research and product development
3.4.2 Product testing
3.4.3 Manufacturing
3.4.4 End users
3.5 Regulatory norms
3.5.1 Regulatory issues of gastroenterology and urology biopsy devices in North America
3.5.2 Regulatory Scenario for breast biopsy in European Union
3.6 Reimbursement scenario
3.6.1 Reimbursement for Breast Cancer Screening in the U.S.
3.6.2 Reimbursement for Breast Reconstruction or Prosthesis
3.7 Patent analysis
3.7.1 The U.S.: Patent analysis, by market participants
3.7.2 Europe: Patent analysis, by market participant
3.7.3 Japan: Patent analysis, by market participants

Access Full Summery @ https://www.alliedmarketresearch.com/press-release/biopsy-devices-market.html

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.